0.05-0.2 mg/day; or clonidine, 0.1-0.3 mg twice daily) or an open-label step 3 agent (hydralazine, 25-100 mg twice daily) could be added. In addition, a number of ALLHAT participants (n=10,337 ...

During the eight-week treatment phase, patients received either moxonidine (0.2 or 0.4 mg/day) or the ACE inhibitor ... acting antihypertensives such as clonidine is widely acknowledged but ...